You are right , they didn't run , but I think YOU not getting ,
They refused to permit 4 doses of leronlimab for
severe /critical , which is very logical base on a half life of the drug...
Dr Lalezari , Dr Yang , Dr Seethamraju asked for it ..
But they such an expert..They said not needed..
I wonder why FDA refused to approve study with 4 weeks of treatment ..hmmmm ..
All IMO.